I am an endocrine surgeon focusing on three endocrine glands: the thyroid, parathyroid and adrenal glands. I also serve as an associate professor at The Ohio State University College of Medicine. In my career, I have performed more than 3,500 neck surgeries and over 150 robotic adrenalectomies. We have the third busiest robotic adrenalectomy program in the country. I was rated in the top 10 percent of physicians in the nation for patient satisfaction in 2016, 2017 and 2018.
In addition to a busy clinical practice, I have a research lab focused on thyroid cancer with two ongoing research projects. The first is dedicated to examining a novel AMPK activator for the treatment of thyroid cancer. I’m currently studying the mechanism of action to potentially be used synergistically with known BRAF inhibitors. My second research project is creating a molecular imaging agent for medullary thyroid cancer (MTC) and parathyroid tumors. The calcium sensing-receptor (CaSR) is expressed primarily on parathyroids, thyroid C-cells and the kidney, as well as in MTC. Further development may allow pre-operative and intra-operative detection to improve surgical outcomes.
Here at Ohio State, we’re fortunate to have one of the few – and best – multidisciplinary treatment teams in the country. We care for patients while also focusing on cutting-edge research. Our team at the OSUCCC – James is a part of two large, multi-investigator NIH grants of more than $25 million dollars funding thyroid cancer research. The camaraderie and expertise among my colleagues is fantastic. There is a singular focus among us, and that’s to create a cancer-free world.
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 12/20/2018, Dr. Phay has reported relationships with the companies or entities listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office.
The overall patient satisfaction rating is an average of all patient responses to the five questions gathered from the Outpatient Oncology survey, developed by Press Ganey Associates for use in oncology clinics across the country. On behalf of The James, Press Ganey administers the survey to patients who see our providers in an outpatient clinic office. For additional information about the patient satisfaction survey, please visit our Patient Satisfaction Survey page
The comments are submitted by patients and reflect their view and opinions. The comments are not endorsed by and do not necessarily reflect the views of The James.
Overall Ratings (out of 137 reviews)
4.8 out of 5
Kept you informed about your condition and treatment
Amount of time spent with you
Concern for your questions and issues
Skill and knowledge
Overall quality of care
Patient Comments (2 total comments)
We love Dr. Phay! His knowledge and advice are trusted and comforting. He's very easy to talk to - a great asset to your facility.